European Healthtech startup funding raised during May 2016.
In May 2016, 33 European Healthtech companies raised a combined €222M across 33 funding rounds, up 298.4% versus May 2015. UK led by capital raised, and Bpifrance was the most active investor. Data as of 9 Jul 2026.
2 exits.
| Company | Stage | Date | Amount |
|---|---|---|---|
| F2G | Growth/Late | May 2016 | €55M |
| CRISPR Therapeutics | Series B | May 2016 | €35M |
| EarlySense | Series D+ | May 2016 | €23M |
| Allecra Therapeutics | Series B |
| May 2016 |
| €22M |
| docplanner | Series C | May 2016 | €18M |
| TalkSpace | Series B | May 2016 | €13M |
| AFFiRiS | Early VC | May 2016 | €10M |
| Biovotion | Series A | May 2016 | €9.0M |
| Diagenode | Early VC | May 2016 | €7.5M |
| Mironid | Series A | May 2016 | €6.0M |
| Natural Cycles | Early VC | May 2016 | €5.5M |
| Echolight | Series A | May 2016 | €4.0M |
| Valbiotis | Early VC | May 2016 | €2.2M |
| Coala Life | Seed | May 2016 | €2.1M |
| ONTOFORCE | Early VC | May 2016 | €2.1M |